市場調査レポート

商品コード

1701734

3Dプリンティング医薬品の市場規模、シェア、成長分析、タイプ別、技術別、材料別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

3D Printed Drugs Market Size, Share, and Growth Analysis, By Type, By Technology, By Material, By Application, By End user, By Region - Industry Forecast 2025-2032

出版日: 2025年04月06日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

3Dプリンティング医薬品市場規模は2023年に5,650万米ドルと評価され、2024年の6,345万米ドルから2032年には1億6,050万米ドルに成長し、予測期間（2025-2032年）のCAGRは12.3％で成長する見通しです。

世界の3Dプリンティング医薬品市場は、有効性を高め副作用を最小限に抑えるカスタマイズされた薬剤製剤への需要の高まりにより、製薬業界で大きな成長を遂げています。この革新的な技術により、レイヤーごとの製造プロセスを通じて正確な投与が可能になり、北米が市場リーダーに位置づけられ、欧州、アジア太平洋がこれに続いています。市場拡大の要因としては、3Dプリンティング技術の進歩、個別化医療の増加、ヘルスケアコスト削減の必要性などが挙げられます。しかし、高い導入コスト、規制上のハードル、厳格な安全基準の必要性などの課題に対処する必要があります。将来のビジネスチャンスは、新規製剤の開発、市場開発、ドラッグデリバリーの変革にあり、製薬企業に新たな収益チャネルを提供します。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Aprecia Pharmaceuticals, LLC（USA）
FabRx Ltd.（UK）
GlaxoSmithKline Plc（UK）
MB Therapeutics（France）

結論と提言

Product Code: SQMIG35I2140

3D Printed Drugs Market size was valued at USD 56.5 million in 2023 and is poised to grow from USD 63.45 million in 2024 to USD 160.5 million by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).

The global 3D Printed Drugs market is experiencing significant growth within the pharmaceutical industry, driven by the increasing demand for customized drug formulations that enhance efficacy and minimize side effects. This innovative technology allows for precise dosing through a layer-by-layer manufacturing process, positioning North America as the market leader, followed by Europe and Asia Pacific. Factors fueling this market expansion include advancements in 3D printing technology, a rise in personalized medicine, and the need to reduce healthcare costs. However, challenges such as high implementation costs, regulatory hurdles, and the necessity for rigorous safety standards must be addressed. Future opportunities lie in developing novel drug formulations, expanding market reach, and transforming drug delivery, offering new revenue channels for pharmaceutical companies.

Top-down and bottom-up approaches were used to estimate and validate the size of the 3D Printed Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

3D Printed Drugs Market Segments Analysis

Global 3D Printed Drugs Market is segmented by Type, Technology, Material, Application, End user and region. Based on Type, the market is segmented into Personalized Medicines, Injectable Implants, Tissue Engineering Scaffolds and Medical Devices. Based on Technology, the market is segmented into Inkjet Printing, Fused Deposition Modeling, Stereolithography and ZipDose Technology. Based on Material, the market is segmented into Polymers, Metal Powder, Ceramics, Biomaterials, and Others. Based on Application, the market is segmented into Orthopedic, Neurology, Dental and Others. Based on End user, the market is segmented into Hospitals & Clinics, Research Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the 3D Printed Drugs Market

The global 3D Printed Drugs market is being significantly propelled by the rising demand for personalized medicine. These tailored treatments are designed to cater to individual patients' unique genetic, environmental, and lifestyle factors, leading to enhanced efficacy, lower side effects, and improved adherence to treatment regimens. The advancement of 3D printing technology allows for the precise customization of drug formulations, enabling the development of intricate geometries and dosing methods that conventional manufacturing can't replicate. The growing prevalence of chronic illnesses, such as cancer and diabetes, underscores the need for innovative, targeted therapies, which 3D printed drugs readily provide. As a result, the market is poised for considerable expansion in the near future.

Restraints in the 3D Printed Drugs Market

The 3D Printed Drugs market faces several notable challenges that may hinder its growth. One primary constraint is the substantial initial investment needed for 3D printing equipment, software, and raw materials, which can limit the ability of small and medium-sized pharmaceutical companies to embrace this technology. Additionally, the production costs for 3D printed drugs are often higher compared to traditional pharmaceuticals, leading to increased prices that may make them less affordable for patients and subsequently decrease demand. Moreover, the regulatory landscape surrounding 3D printed drugs remains in development, with lengthy and costly approval processes that can further raise prices and restrict patients' access to these innovative treatments.

Market Trends of the 3D Printed Drugs Market

The global 3D Printed Drugs market is witnessing a burgeoning trend driven by collaborations between pharmaceutical firms and 3D printing companies. These partnerships are fostering rapid innovation, enabling the development of complex drug formulations and personalized medications with precise dosing. By leveraging advanced 3D printing technologies, these alliances are expediting the introduction of novel drugs and drug delivery mechanisms, thus enhancing patient care and outcomes. As this collaborative approach gains momentum, it is poised to accelerate growth within the market, with projections indicating substantial advancements in the industry over the coming years. This synergy is set to revolutionize drug production and delivery, making it more efficient and patient-centric.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global 3D Printed Drugs Market Size by Type & CAGR (2025-2032)

Market Overview
Personalized Medicines
- Tablet
- Capsule
- Others
Injectable Implants
Tissue Engineering Scaffolds
Medical Devices

Global 3D Printed Drugs Market Size by Technology & CAGR (2025-2032)

Market Overview
Inkjet Printing
Fused Deposition Modeling
Stereolithography
ZipDose Technology

Global 3D Printed Drugs Market Size by Material & CAGR (2025-2032)

Market Overview
Polymers
Metal Powders
Ceramics
Biomaterials
Others

Global 3D Printed Drugs Market Size by Application & CAGR (2025-2032)

Market Overview
Orthopedic
Neurology
Dental
Others

Global 3D Printed Drugs Market Size by End user & CAGR (2025-2032)

Market Overview
Hospitals & Clinics
Research Laboratories
Others

Global 3D Printed Drugs Market Size & CAGR (2025-2032)

North America (Type, Technology, Material, Application, End user)
- US
- Canada
Europe (Type, Technology, Material, Application, End user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Technology, Material, Application, End user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Technology, Material, Application, End user)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Technology, Material, Application, End user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Aprecia Pharmaceuticals, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FabRx Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MB Therapeutics (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

3Dプリンティング医薬品の市場規模、シェア、成長分析、タイプ別、技術別、材料別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

3D Printed Drugs Market Size, Share, and Growth Analysis, By Type, By Technology, By Material, By Application, By End user, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

3Dプリンティング医薬品市場規模：タイプ別& CAGR（2025-2032）

3Dプリンティング医薬品市場規模：技術別& CAGR（2025-2032）

3Dプリンティング医薬品市場規模：材料別& CAGR（2025-2032）

3Dプリンティング医薬品市場規模：用途別& CAGR（2025-2032）

3Dプリンティング医薬品市場規模：エンドユーザー別& CAGR（2025-2032）

3Dプリンティング医薬品市場規模：地域別& CAGR（2025-2032）